These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 25782205

  • 1. [Current guidelines for treatment of dyslipidemia in kidney diseases].
    Jędras M, Dylewska M.
    Wiad Lek; 2014; 67(3):426-8. PubMed ID: 25782205
    [Abstract] [Full Text] [Related]

  • 2. Management of dyslipidemias in patients with diabetes and chronic kidney disease.
    Molitch ME.
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1090-9. PubMed ID: 17699330
    [Abstract] [Full Text] [Related]

  • 3. Managing dyslipidemia in chronic kidney disease.
    Harper CR, Jacobson TA.
    J Am Coll Cardiol; 2008 Jun 24; 51(25):2375-84. PubMed ID: 18565393
    [Abstract] [Full Text] [Related]

  • 4. Safety and efficacy of statin treatment alone and in combination with fibrates in patients with dyslipidemia: a meta-analysis.
    Choi HD, Shin WG.
    Curr Med Res Opin; 2014 Jan 24; 30(1):1-10. PubMed ID: 24063624
    [Abstract] [Full Text] [Related]

  • 5. Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence.
    Kanbay M, Turgut F, Covic A, Goldsmith D.
    J Nephrol; 2009 Jan 24; 22(5):598-609. PubMed ID: 19809992
    [Abstract] [Full Text] [Related]

  • 6. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008 Jan 24; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]

  • 7. The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges.
    Ahmed MH, Al-Atta A, Hamad MA.
    Expert Opin Pharmacother; 2012 Sep 24; 13(13):1901-9. PubMed ID: 22770622
    [Abstract] [Full Text] [Related]

  • 8. Diabetic dyslipidemia: a practical guide to therapy.
    Tovar JM, Bazaldua OV, Loffredo A.
    J Fam Pract; 2008 Jun 24; 57(6):377-88. PubMed ID: 18544321
    [Abstract] [Full Text] [Related]

  • 9. The dyslipidemia of chronic renal disease: effects of statin therapy.
    Ozsoy RC, van Leuven SI, Kastelein JJ, Arisz L, Koopman MG.
    Curr Opin Lipidol; 2006 Dec 24; 17(6):659-66. PubMed ID: 17095911
    [Abstract] [Full Text] [Related]

  • 10. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
    Fazio S.
    Clin Ther; 2008 Feb 24; 30(2):294-306. PubMed ID: 18343268
    [Abstract] [Full Text] [Related]

  • 11. Ezetimibe as a potential treatment for dyslipidemia associated with chronic renal failure and renal transplant.
    Ahmed MH, Khalil AA.
    Saudi J Kidney Dis Transpl; 2010 Nov 24; 21(6):1021-9. PubMed ID: 21060168
    [Abstract] [Full Text] [Related]

  • 12. Plasma lipoprotein abnormalities in hemodialysis patients--clinical implications and therapeutic guidelines.
    Shoji T, Nishizawa Y.
    Ther Apher Dial; 2006 Aug 24; 10(4):305-15. PubMed ID: 16911182
    [Abstract] [Full Text] [Related]

  • 13. Combination therapy with statins and omega-3 fatty acids.
    Nambi V, Ballantyne CM.
    Am J Cardiol; 2006 Aug 21; 98(4A):34i-38i. PubMed ID: 16919515
    [Abstract] [Full Text] [Related]

  • 14. [Statins and kidney disease].
    Bigazzi R, Grimaldi D, Bianchi S.
    G Ital Nefrol; 2012 Aug 21; 29(2):160-73. PubMed ID: 22538946
    [Abstract] [Full Text] [Related]

  • 15. [Statins in chronic renal disease].
    Ferreira SR, Rocha AM, Saraiva JF.
    Arq Bras Cardiol; 2005 Oct 21; 85 Suppl 5():45-9. PubMed ID: 16400399
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus.
    Jones PH.
    Am J Cardiol; 2007 Feb 19; 99(4A):133B-140B. PubMed ID: 17307065
    [Abstract] [Full Text] [Related]

  • 17. Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease.
    Khurana M, Silverstein DM.
    Pediatr Nephrol; 2015 Dec 19; 30(12):2073-84. PubMed ID: 25801207
    [Abstract] [Full Text] [Related]

  • 18. Dyslipidemias in chronic kidney disease.
    Szromba C.
    Nephrol Nurs J; 2006 Dec 19; 33(5):575-6. PubMed ID: 17044444
    [No Abstract] [Full Text] [Related]

  • 19. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW.
    Curr Med Res Opin; 2001 Dec 19; 17(1):60-73. PubMed ID: 11464448
    [Abstract] [Full Text] [Related]

  • 20. The new dyslipidemia guidelines: what is the debate?
    Anderson TJ, Mancini GB, Genest J, Grégoire J, Lonn EM, Hegele RA.
    Can J Cardiol; 2015 May 19; 31(5):605-12. PubMed ID: 25816728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.